Comprehensive analysis to explain reduced or increased SOD1 enzymatic activity in ALS patients and their relatives

References

• Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603–15.
   PubMed Web of Science ®Google Scholar
• Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Brännström T, Gredal O, et al. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain. 2004;127:73–88.
   PubMed Web of Science ®Google Scholar
• Jonsson PA, Graffmo KS, Andersen PM, Brännström T, Lindberg M, Oliveberg M, et al. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain. 2006;129:451–64.
   PubMed Web of Science ®Google Scholar
• Sapp PC, Rosen DR, Hosler BA, Esteban J, McKenna-Yasek D, O'Regan JP, et al. Identification of three novel mutations in the gene for Cu/Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscul Disord. 1995;5:353–7.
   PubMed Web of Science ®Google Scholar
• Zu JS, Deng HX, Lo TP, Mitsumoto H, Ahmed MS, Hung WY, et al. Exon 5 encoded domain is not required for the toxic function of mutant SOD1 but essential for the dismutase activity: identification and characterization of two new SOD1 mutations associated with familial amyotrophic lateral sclerosis. Neurogenetics. 1997;1:65–71.
   PubMed Web of Science ®Google Scholar
• Birve A, Neuwirth C, Weber M, Marklund SL, Nilsson A-C, Jonsson PA, et al. A novel SOD1 splice site mutation associated with familial ALS revealed by SOD activity analysis. Hum Mol Genet. 2010;19:4201–6.
   PubMed Web of Science ®Google Scholar
• Valdmanis PN, Belzil VV, Lee J, Dion PA, St-Onge J, Hince P, et al. A mutation that creates a pseudoexon in SOD1 causes familial ALS. Ann Hum Genet. 2009;73:652–7.
   PubMed Web of Science ®Google Scholar
• Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13:1396–403.
   PubMed Web of Science ®Google Scholar
• Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, et al. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One. 2010;5:e11552
   PubMed Web of Science ®Google Scholar
• Forsberg K, Andersen PM, Marklund SL, Brännström T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2011;121:623–34.
   PubMed Web of Science ®Google Scholar
• Pokrishevsky E, Grad LI, Yousefi M, Wang J, Mackenzie IR, Cashman NR. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis. PLoS One. 2012;7:e35050.
   PubMed Web of Science ®Google Scholar
• Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29:824–8.
   PubMed Web of Science ®Google Scholar
• Ferraiuolo L, Meyer K, Sherwood TW, Vick J, Likhite S, Frakes A, et al. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc Natl Acad Sci USA. 2016;113:E6496-E6505. Epub pii:201607496 Sep 29 ahead of print.
   PubMed Web of Science ®Google Scholar
• Graffmo KS, Forsberg K, Bergh J, Birve A, Zetterstrom P, Andersen PM, et al. Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. Hum Mol Genet. 2013;22:51–60.
   PubMed Web of Science ®Google Scholar
• Fagan JM, Waxman L, Goldberg AL. Red blood cells contain a pathway for the degradation of oxidant-damaged hemoglobin that does not require ATP or ubiquitin. J Biol Chem. 1986;261:5705–13.
   PubMed Web of Science ®Google Scholar
• Khandros E, Thom CS, D'Souza J, Weiss MJ. Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia. Blood. 2012;119:5265–75.
   PubMed Web of Science ®Google Scholar
• Bowling AC, Barkowski EE, McKenna-Yasek D, Sapp P, Horvitz HR, Beal MF, et al. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J Neurochem. 1995;64:2366–9.
   PubMed Web of Science ®Google Scholar
• Jonsson PA, Graffmo KS, Brannstrom T, Nilsson P, Andersen PM, Marklund SL. Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1. J Neuropathol Exp Neurol. 2006;65:1126–36.
   PubMed Web of Science ®Google Scholar
• Sato T, Nakanishi T, Yamamoto Y, Andersen PM, Ogawa Y, Fukada K, et al. Rapid disease progression correlates with instability of mutant SOD1 in familial ALS. Neurology. 2005;65:1954–7.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol. 2005;12:921–38.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Nilsson P, Forsgren L, Marklund SL. CuZn-superoxide dismutase, extracellular superoxide dismutase, and glutathione peroxidase in blood from individuals homozygous for Asp90Ala CuZu-superoxide dismutase mutation. J Neurochem. 1998;70:715–20.
   PubMed Web of Science ®Google Scholar
• Marklund S. Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase. J Biol Chem. 1976;251:7504–7.
   PubMed Web of Science ®Google Scholar
• Marklund SL, Andersen PM, Forsgren L, Nilsson P, Ohlsson PI, Wikander G, et al. Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J Neurochem. 1997;69:675–81.
   PubMed Web of Science ®Google Scholar
• Bertini I, Piccioli M, Viezzoli MS, Chiu CY, Mullenbach GT. A spectroscopic characterization of a monomeric analog of copper, zinc superoxide dismutase. Eur Biophys J. 1994;23:167–76.
   PubMed Web of Science ®Google Scholar
• Huppke P, Brendel C, Korenke GC, Marquardt I, Donsante A, Yi L, et al. Molecular and biochemical characterization of a unique mutation in CCS, the human copper chaperone to superoxide dismutase. Hum Mutat. 2012;33:1207–15.
   PubMed Web of Science ®Google Scholar
• Brotherton T, Polak M, Kelly C, Birve A, Andersen P, Marklund SL, et al. A novel ALS SOD1 C6S mutation with implications for aggregation related toxicity and genetic counseling. Amyotroph Lateral Scler. 2011;12:215–9.
   PubMed Web of Science ®Google Scholar
• Synofzik M, Ronchi D, Keskin I, Basak AN, Wilhelm C, Gobbi C, et al. Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS. Hum Mol Genet. 2012;21:3568–74.
   PubMed Web of Science ®Google Scholar
• Lindberg MJ, Bystrom R, Boknas N, Andersen PM, Oliveberg M. Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc Natl Acad Sci USA. 2005;102:9754–9.
   PubMed Web of Science ®Google Scholar